Package Leaflet: Information for the User
Tramadol Basi 50 mg/ml Solution for Injection EFG
tramadol hydrochloride
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the Pack
Tramadol - the active substance of Tramadol Basi - is an analgesic belonging to the group of opioids that acts on the central nervous system. This medicine relieves pain by acting on specific nerve cells in the spinal cord and brain.
Tramadol Basi is indicated for the treatment of moderate to severe pain.
Do not use Tramadol Basi
Warnings and Precautions
Consult your doctor or pharmacist before starting to use this medicine
Respiratory disorders related to sleep
Tramadol may cause respiratory disorders related to sleep, such as sleep apnea (pauses in breathing during sleep) and sleep-related hypoxemia (low oxygen level in the blood). The symptoms may include pauses in breathing during sleep, waking up during the night due to difficulty breathing, difficulty staying asleep, or excessive daytime sleepiness. If you or someone else notices these symptoms, inform your doctor. Your doctor may consider reducing the dose.
Consult your doctor, pharmacist, or nurse if you experience any of the following symptoms while using this medicine:
Extreme fatigue, loss of appetite, severe abdominal pain, nausea, vomiting, or low blood pressure. They may be indicators of adrenal insufficiency (low cortisol levels). If you have these symptoms, contact your doctor, who will decide if you need to take hormonal supplements.
Tolerance, dependence, and addiction
This medicine contains tramadol, which is an opioid medicine. Repeated use of opioids can make the medicine less effective (the body gets used to it, which is known as pharmacological tolerance). Repeated use of Tramadol Basi can also lead to dependence, abuse, and addiction, which could result in a potentially life-threatening overdose. The risk of these side effects may be greater with a higher dose and longer use.
Dependence or addiction can cause a feeling of lack of control over the amount of medicine you need to use or how often you need to use it. The risk of dependence or addiction varies from person to person. The risk of becoming dependent on or addicted to Tramadol Basi may be greater if:
If you notice any of the following symptoms while using Tramadol Basi, it could be a sign of dependence or addiction:
If you notice any of these signs, consult your doctor to determine the best treatment option for you, when it is appropriate to stop the medicine, and how to do it safely (see section 3, if you stop treatment with Tramadol Basi).
If you experience any of the problems mentioned during treatment with this medicine or if you have had them before, inform your doctor.
Children and Adolescents
Use in children with respiratory problems:
Tramadol is not recommended for use in children with respiratory problems, as the symptoms of tramadol toxicity may worsen in these children.
Other medicines and Tramadol Basi
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
If you are using tramadol, you should not take MAO inhibitors (certain medicines used to treat depression).
The analgesic effect of tramadol may be reduced and the duration of exposure shorter if you are also taking medicines that contain:
Your doctor will tell you if you should use this medicine and what dose to use.
The risk of side effects increases:
Concomitant use of tramadol and sedatives such as benzodiazepines or other related medicines increases the risk of drowsiness, difficulty breathing (respiratory depression), coma, and can be potentially life-threatening. Due to this situation, concomitant use should only be considered when other treatment options are not possible.
However, if your doctor prescribes tramadol along with sedative medicines, you should limit the dose and duration of concomitant treatment.
Tell your doctor about all sedative medicines you are taking and carefully follow your doctor's dosage recommendations. It may be helpful to inform friends or family members to be aware of the signs and symptoms indicated above. Contact your doctor when you have these symptoms.
Using Tramadol Basi with food and alcohol
Do not drink alcohol during treatment with tramadol, as its effects may be enhanced. Food does not affect the effect of tramadol.
Pregnancy, Breast-feeding, and Fertility
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
There is very little information available on the safety of tramadol during pregnancy. Therefore, you should not use this medicine if you are pregnant.
Chronic treatment during pregnancy may cause withdrawal symptoms in newborns.
Tramadol is generally not recommended during breast-feeding. Tramadol is excreted in breast milk. For this reason, you should not use this medicine more than once during breast-feeding, or if you use it more than once, you should interrupt breast-feeding.
Based on human experience, tramadol is not expected to affect fertility in men and women.
Driving and using machines
Tramadol may cause drowsiness, dizziness, and blurred vision, and may affect your reactions. If you feel that your reactions are affected, do not drive a car or other vehicle, do not use electric tools or machines, and do not work without a secure grip.
Tramadol Basi contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per ml; this is essentially “sodium-free”.
Follow exactly the instructions for administration of this medicine given by your doctor. In case of doubt, consult your doctor or pharmacist again.
Before starting treatment and regularly during treatment, your doctor will also explain what you can expect from the use of Tramadol Basi, when and for how long you should use it, when you should contact your doctor, and when you should stop using it (see also section 2).
The dose should be adjusted according to the intensity of the pain and your individual sensitivity to pain. Generally, you should receive the lowest effective analgesic dose.
Normally, daily doses of up to 8 ml of tramadol (equivalent to 400 mg of tramadol hydrochloride) are sufficient. In exceptional cases, if clinically necessary, your doctor may prescribe a higher daily dose.
Unless your doctor has prescribed otherwise, the usual dose is:
Adults and adolescents over 12 years
Depending on the pain, you will be given 1 to 2 ml of tramadol (equivalent to 50 - 100 mg of tramadol hydrochloride).
Depending on the pain, the effect lasts from 4 to 8 hours.
At the end of this leaflet, you can find additional information for doctors and healthcare professionals.
Use in children
Children over 1 year
Normally, a single dose of tramadol is 1 to 2 mg/kg body weight. You should choose the lowest effective analgesic dose. The daily dose should not exceed the lower of the following doses: 8 mg/kg body weight or 400 mg of active substance.
At the end of this leaflet, you can find additional information for doctors and healthcare professionals.
Elderly patients
In elderly patients (over 75 years), the elimination of tramadol may be delayed. If this applies to you, your doctor may prolong the dosing interval.
Severe kidney or liver disease / patients on dialysis
You should not use tramadol if you have severe liver or kidney failure. If your failure is mild or moderate, your doctor may recommend that you increase the interval between doses.
How and when to use Tramadol Basi
Tramadol should be injected slowly, usually into a vein in the arm, muscle (usually the buttocks), or under the skin. Alternatively, tramadol can be diluted and administered intravenously by infusion.
For how long to use Tramadol Basi
Tramadol should not be administered for longer than strictly necessary. If prolonged analgesic treatment is considered necessary, your doctor will carefully monitor you and decide if you should continue using tramadol and at what dose.
If you think the effect of tramadol is too strong or too weak, tell your doctor or pharmacist.
If you use more Tramadol Basi than you should
If you have used an additional dose of tramadol by mistake, it will generally not have negative effects. You should continue with the next dose of tramadol as prescribed.
In case of overdose, the following symptoms may occur: miosis (narrow pupils), vomiting, low blood pressure, rapid heartbeat, circulatory collapse, changes in consciousness up to coma (deep unconsciousness), generalized epileptic seizures (severe), as well as difficulty breathing up to respiratory arrest.
If these signs occur, contact your doctor immediately.
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount used.
If you forget to use Tramadol Basi
If you forget to use tramadol, it is likely that the pain will return. Do not take a double dose to make up for forgotten doses. Continue using Tramadol Basi as before.
If you stop treatment with Tramadol Basi
If you stop or finish treatment with tramadol too early, it is likely that the pain will return. If you want to stop treatment due to side effects, consult your doctor. You should not stop using this medicine suddenly unless your doctor tells you to.
If you want to stop using your medicine, talk to your doctor first, especially if you have been using it for a long time. Your doctor will inform you when and how to stop it, which can be done by gradually reducing the dose to reduce the likelihood of unnecessary side effects (withdrawal symptoms).
Generally, no side effects are expected when stopping treatment with tramadol. However, unwanted effects may occur in some patients who have been using tramadol for a long time and suddenly stop using the medicine. They may feel agitated, anxious, nervous, or trembly. They may be overactive, have difficulty sleeping, and experience gastrointestinal discomfort. Very few people may have panic attacks, hallucinations, unusual perceptions such as itching, tingling, and numbness, and ringing in the ears (tinnitus). Very rarely, unusual symptoms of the central nervous system such as confusion, illusion, change in perception of personality (depersonalization), and change in perception of reality (derealization) and delusions of persecution (paranoia) have been detected. If you experience any of these side effects after stopping treatment with tramadol, consult your doctor.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
You should consult your doctor immediately if you experience symptoms of an allergic reaction such as swelling of the face, tongue, and/or throat and/or difficulty swallowing or hives along with difficulty breathing.
The most frequent adverse effects during treatment with tramadol are nausea and dizziness, which occur in more than 1 in 10 people.
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Frequency not known: cannot be estimated from the available data
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Keep this medicine in a safe and protected place, where others cannot access it. This medicine can cause serious harm and even be fatal to people who have not been prescribed it.
Store below 30°C.
For single use. This medicine must be used immediately after opening the ampoule/dilution.
Do not use this medicine after the expiration date that appears on the packaging and on the ampoules after "EXP". The expiration date is the last day of the month indicated.
Do not use this medicine if you notice visible signs of deterioration.
Medicines should not be thrown away through the sewers or in the trash. Ask your pharmacist how to dispose of the packaging and medicines that you no longer need. This way, you will help protect the environment.
Composition of Tramadol Basi
Appearance of the Product and Package Contents
Tramadol Basi is a clear and colorless solution.
The injectable solution is presented in type I colorless glass ampoules of 2 ml (packaging of 10 and 50 ampoules).
Marketing Authorization Holder
Laboratórios Basi - Indústria Farmacêutica, S.A.
Parque Industrial Manuel Lourenço Ferreira, Lote 15
3450-232 Mortágua
Portugal
Tel: + 351 231 920 250 | Fax: + 351 231 921 055
E-mail: basi@basi.pt
Manufacturer
Laboratórios Basi - Indústria Farmacêutica, S.A.
Parque Industrial Manuel Lourenço Ferreira, Lotes 8, 15 e 16
3450-232 Mortágua
Portugal
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Local Representative
Laphysan, S.A.U.
Calle Anabel Segura 11,
Complejo Empresarial Albatros, Edificio A, Planta 4, puerta D,
28108 Alcobendas (Madrid)
Date of the Last Revision of this Prospectus: July 2024
Detailed and updated information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)
------------------------------------------------------------------------------------------------------------------------
This information is intended only for healthcare professionals:
Information on the Handling of Tramadol Basi
Medicines intended for parenteral administration must be visually inspected before use. This medicine should only be administered if the solution is transparent and free of visible particles, and if the packaging is not damaged.
This medicine is for single use. Any unused amount must be discarded.
Instructions for Opening OPC Ampoules (One-Point-Cut)
Administration Information
For moderate pain, 1 ml of this medicine is administered (equivalent to 50 mg of tramadol hydrochloride). If pain relief is not achieved after 30 to 60 minutes, an additional 1 ml of tramadol can be administered. If the need is greater in severe pain, 2 ml of tramadol (equivalent to 100 mg of tramadol hydrochloride) are administered.
For the treatment of severe postoperative pain, in the first hours after surgery, a higher dose may be necessary (pain treatment as needed).
The needs during a 24-hour period are normally not greater than during conventional administration.
Tramadol Basi is injected intravenously (usually in a vein of the arm), intramuscularly (usually in the gluteal muscle), or subcutaneously (under the skin). Intravenous administration should be slow, for example, 1 ml of this medicine (equivalent to 50 mg of tramadol hydrochloride) per minute.
Alternatively, this medicine can be diluted with an appropriate perfusion solution (e.g., 0.9% sodium chloride, 5% glucose solution, Ringer's solution, or Ringer's lactate solution) and used directly for intravenous perfusion or patient-controlled analgesia.
Incompatibilities of Tramadol Basi
It has been shown that the injectable solution of tramadol is incompatible (immiscible) with solutions of diclofenac, indomethacin, phenylbutazone, diazepam, flunitrazepam, midazolam, and nitroglycerin.
How to Use Tramadol Basi for the Treatment of Children Over 1 Year(see section 3 "How and When to Use Tramadol Basi?")
Calculation of Injection Volume
Table: Dilution of Tramadol Basi (appropriate diluted solution, see section 3 "How and When to Use Tramadol Basi?")
Concentration of diluted injectable solution (mg of tramadol hydrochloride/ml) | Tramadol Basi + added solvent |
25.0 mg/ml | 2 ml + 2 ml |
16.7 mg/ml | 2 ml + 4 ml |
12.5 mg/ml | 2 ml + 6 ml |
10.0 mg/ml | 2 ml + 8 ml |
8.3 mg/ml | 2 ml + 10 ml |
7.1 mg/ml | 2 ml + 12 ml |
6.3 mg/ml | 2 ml + 14 ml |
5.6 mg/ml | 2 ml + 16 ml |
5.0 mg/ml | 2 ml + 18 ml |
According to your calculations, dilute the contents of the ampoule of this medicine by adding the appropriate amount of solvent, mix, and administer the calculated volume of the diluted solution. Discard the remaining injectable solution.
Example
For a child who weighs 27 kg and is to be administered a dose of 1.5 mg of tramadol hydrochloride per kg of body weight.
The total required dose is 27 kg x 1.5 mg/kg = 40.5 mg of tramadol hydrochloride.
An appropriate concentration of the diluted injectable solution is 10.0 mg/ml, so the volume to be injected would be approximately 4 ml (40.5 mg/10.0 mg/ml = 4.05 ml).
According to the above, 1 ml of this medicine is diluted by adding 4 ml of solvent (e.g., 0.9% sodium chloride, 5% glucose solution, Ringer's solution, or Ringer's lactate solution), resulting in a diluted solution of 10 mg of tramadol hydrochloride per milliliter.
From the diluted solution, 4 ml (40 mg of tramadol hydrochloride) are administered.